Mark Sheptoff Financial Planning, LLC Veracyte, Inc. Transaction History
Mark Sheptoff Financial Planning, LLC
- $197 Million
- Q3 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 1,200 shares of VCYT stock, worth $47,220. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,200
Previous 1,200
-0.0%
Holding current value
$47,220
Previous $32,000
28.13%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding VCYT
# of Institutions
324Shares Held
78.8MCall Options Held
94.6KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA8.5MShares$335 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$307 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI7.37MShares$290 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.47MShares$176 Million1.08% of portfolio
-
State Street Corp Boston, MA4.2MShares$165 Million0.01% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.82B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...